HomeInsightsStock Comparison

Beta Drugs Ltd vs Concord Biotech Ltd Stock Comparison

Beta Drugs Ltd vs Concord Biotech Ltd Stock Comparison

Last Updated on: May 20, 2025

Key Highlights

  • The Latest Trading Price of Beta Drugs Ltd is ₹ 1800 as of 19 May 15:30.
  • The P/E Ratio of Beta Drugs Ltd changed from 4.1 on March 2020 to 32.5 on March 2024 . This represents a CAGR of 51.29% over 5 yearsThe P/E Ratio of Concord Biotech Ltd changed from 51.7 on March 2024 to 51.7 on March 2024 . This represents a CAGR of 0.00% over 1 years.
  • The Market Cap of Beta Drugs Ltd changed from ₹ 38.46 crore on March 2020 to ₹ 1186 crore on March 2024 . This represents a CAGR of 98.53% over 5 yearsThe Market Cap of Concord Biotech Ltd changed from ₹ 15922 crore on March 2024 to ₹ 15922 crore on March 2024 . This represents a CAGR of 0.00% over 1 years.
  • The revenue of Beta Drugs Ltd for the Dec '24 is ₹ 0 crore as compare to the Sep '24 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Concord Biotech Ltd for the Dec '24 is ₹ 260.78 crore as compare to the Sep '24 revenue of ₹ 320.21 crore. This represent the decline of -18.56%.
  • The ebitda of Beta Drugs Ltd for the Dec '24 is ₹ 0 crore as compare to the Sep '24 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Concord Biotech Ltd for the Dec '24 is ₹ 114.51 crore as compare to the Sep '24 ebitda of ₹ 143.75 crore. This represent the decline of -20.34%.
  • The net profit of Beta Drugs Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Concord Biotech Ltd changed from ₹ 54.49 crore to ₹ 75.92 crore over 7 quarters. This represents a CAGR of 20.87% .
  • The Dividend Payout of Beta Drugs Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Concord Biotech Ltd changed from 24.05 % on March 2020 to 30.03 % on March 2024 . This represents a CAGR of 4.54% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Beta Drugs Ltd

  • Beta Drugs Limited was incorporated as a private limited company with the name 'Beta Drugs Private limited' at Himachal Pradesh on September 21, 2005.
  • Subsequently, the company was converted in to public limited company and the name of the company was changed to 'Beta Drugs Limited' on August 11, 2017 Beta Drugs is a part of Adley Group.
  • Adley Group was founded in the year 1985, by its promoter Vijay Batra, who has more than twenty five years of experience in manufacture of pharmaceutical products in India.
  • The Company is a pharmaceutical formulation manufacturing company engaged in developing, manufacturing and marketing of drug products for domestic and international customers.
  • The Promoter Vijay Batra, took over the company from Kiran Goyal, Deepak Kumar Prince Bharti and Rohit Bansal in the year 2014.

About Concord Biotech Ltd

  • Concord Biotech Limited was originally incorporated as Servomed Pharmaceuticals Private Limited' at Ahmedabad, Gujarat as a Private Limited Company dated November 23, 1984, issued by the Registrar of Companies.
  • Thereafter, name of the Company was changed to Concord Biotech Limited' dated February 16, 2001, which became a Public Company and a fresh Certificate of Incorporation dated November 7, 2001 was issued by the RoC. The Company is an India-based bio pharma and one of the leading global developers and manufacturers of select fermentation-based APIs across immunosuppressants and oncology in terms of market share, based on volume in supplying to over 70 countries including regulated markets, such as the United States, Europe and Japan, and India.
  • Presently, it is engaged in research and development, manufacturing, marketing and selling of pharmaceutical products.

Beta Drugs Ltd News Hub

News

Beta Drugs to conduct board meeting

Beta Drugs will hold a meeting of the Board of Directors of the Company on 15 May 2025. Po...

Read more

10 May 2025 10:59

News

Beta Drugs announces board meeting date

Beta Drugs will hold a meeting of the Board of Directors of the Company on 27 March 2025. ...

Read more

20 Mar 2025 14:34

News

Beta Drugs to conduct board meeting

Beta Drugs will hold a meeting of the Board of Directors of the Company on 5 February 2025...

Read more

03 Feb 2025 10:49

News

Beta Drugs schedules EGM

Beta Drugs announced that an Extra Ordinary General Meeting (EGM) of the Company will be h...

Read more

28 Nov 2024 15:41

News

Beta Drugs to conduct board meeting

Beta Drugs will hold a meeting of the Board of Directors of the Company on 6 November 2024...

Read more

04 Nov 2024 14:01

News

Beta Drugs to conduct EGM

Beta Drugs announced that an Extra Ordinary General Meeting (EGM) of the Company will be h...

Read more

21 Oct 2024 13:59

Concord Biotech Ltd News Hub

News

Concord Biotech gets US FDA nod for marketing multiple sclerosis drug Teriflunomide

Teriflunomide tablets are used for the treatment of patients with relapsing forms of multi...

Read more

09 Apr 2025 09:18

News

Concord Biotech commences production at Unit 4 in Valthera

Concord Biotech has successfully commissioned and commenced production of injectable at it...

Read more

25 Mar 2025 12:21

News

Concord Biotech invest Rs 6.09 cr in Clean Max

Concord Biotech has invested Rs 6.09 crore through subscription to Right issue of shares i...

Read more

04 Mar 2025 12:19

News

Concord Biotech rebounds after 7-day losing streak

This rebound follows a steep decline of 28.15% over the preceding seven trading sessions, ...

Read more

18 Feb 2025 13:54

News

Concord Biotech Ltd Slips 10.64%

Concord Biotech Ltd fell 10.64% today to trade at Rs 1885.35. The BSE Healthcare index is ...

Read more

14 Feb 2025 09:30

News

Concord Biotech drops after Q3 PAT falls 2% YoY to Rs 76 cr

Revenue from operations increased 1.4% YoY to Rs 244.22 crore in Q3 FY25. Profit before ta...

Read more

14 Feb 2025 12:05

SWOT Analysis Of Concord Biotech Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Beta Drugs Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Concord Biotech Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Beta Drugs Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Beta Drugs Ltd and Concord Biotech Ltd

Which company has a larger market capitalization, Beta Drugs Ltd or Concord Biotech Ltd?

Market cap of Beta Drugs Ltd is 1,817 Cr while Market cap of Concord Biotech Ltd is 15,930 Cr

What are the key factors driving the stock performance of Beta Drugs Ltd and Concord Biotech Ltd?

The stock performance of Beta Drugs Ltd and Concord Biotech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Beta Drugs Ltd and Concord Biotech Ltd?

As of May 20, 2025, the Beta Drugs Ltd stock price is INR ₹1800.0. On the other hand, Concord Biotech Ltd stock price is INR ₹1522.8.

How do dividend payouts of Beta Drugs Ltd and Concord Biotech Ltd compare?

To compare the dividend payouts of Beta Drugs Ltd and Concord Biotech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions